ECFS (EYIM) 2026 Optimization of blocker oligonucleotides as therapies to correct consequences of deep intronic mutations
C. Felgerolle, K. Delétang, I. Pranke, B. Simmoneau, L. Damy, F. Becq, B.Duriez, P. Fanen, I. Sermet, M. Taulan-Cadars – Phymedexp, Inserm U1046 / U1151, CNRS – University of Montpellier, Creteil -France
ECFS 2025 – CFTR stabilizers as therapeutic tools in cystic fibrosis
– M. Sinane, K. Deletang, C. Felgerolle, C. Teko-Agbo, P. Boisguerin, M. Taulan-Cadars – Phymedexp, Inserm U1046, University of Montpellier, France.